A new medication for treatment-resistant depression may help a subset of people who carry a specific genetic marker.

An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.

New research from the University of Wisconsin–Madison reveals that dysfunction in a protein essential to maintaining ...

Researchers used cryo-EM to study how the HIV enzyme integrase arranges in 3D to slip its DNA into the host genome and pack ...

Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient ...

For decades, scientists believed the essence of life was written solely in four chemical bases: A, C, T, and G. Together, ...

The 55th Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research has been awarded to professor Steven ...

Scientists reengineered chemo drug into spherical nucleic acids (SNAs), a globular form of DNA. Team tested the repackaged ...

Selecting the right business structure forms the groundwork for organizational effectiveness, asset protection, and financial transparency. This decision influences the company’s ability to raise ...

Frogs have made significant contributions to Fred Hutch science over the years as a model organism that shares much of our ...

Why Some People Are Born to Be Afraid Scientists are discovering that our tendency to develop certain phobias might be ...